Aptamer Group plc (LON:APTA – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Wednesday. The company traded as low as GBX 0.27 and last traded at GBX 0.27, with a volume of 6,358,435 shares trading hands. The stock had previously closed at GBX 0.28.
Aptamer Group Stock Performance
The business has a 50 day moving average price of GBX 0.33 and a two-hundred day moving average price of GBX 0.55. The company has a market cap of £9.81 million, a P/E ratio of -2.57 and a beta of 0.87.
Aptamer Group (LON:APTA – Get Free Report) last posted its quarterly earnings results on Tuesday, October 13th. The company reported GBX (0.07) earnings per share (EPS) for the quarter. Aptamer Group had a negative return on equity of 46.61% and a negative net margin of 120.60%.
Aptamer Group Company Profile
Aptamer Group is a leading provider of aptamer selection services and developer of aptamer-based reagents for use in research, bioprocessing, diagnostic, and therapeutic applications. Headquartered in York, UK, the Company partners globally to deliver aptamer-based solutions that drive discovery and development across the life sciences.
Aptamer Group has developed the proprietary Optimer® platform technology that drives three distinct businesses: Aptamer Solutions, Aptamer Diagnostics and Aptamer Therapeutics.
Read More
- Five stocks we like better than Aptamer Group
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for Aptamer Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptamer Group and related companies with MarketBeat.com's FREE daily email newsletter.
